Celcarb 150mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Carboplatin (10mg/ml)
Overview Celcarb 150mg Injection
Carbicel 150mg Injection treats ovarian and small-cell lung cancers by inhibiting or reducing cancerous cell proliferation. Administered intravenously under medical supervision, dosage and frequency are determined individually by your physician based on your condition, and may vary. Strict adherence to prescribed instructions is vital; incorrect usage or overdosing can have severe consequences. Therapeutic benefits might not be apparent for weeks or months; discontinue only under physician guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitor blood cell levels, plus heart, liver, and uric acid. Report any allergic reactions like skin rash, itching, or breathing difficulties. Inform your healthcare provider of all other medications, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Primary Ingredients of Celcarb 150mg Injection
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Celcarb 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Celcarb 150mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Celcarb 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Celcarb 150mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Celcarb 150mg Injection works:
OncoCel 150mg Injection is a cancer treatment agent. Its mechanism of action involves disrupting the genetic makeup (DNA and RNA) of malignant cells, thereby halting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Celcarb 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Celcarb 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Celcarb 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity.
DrivingUNSAFE
Administration of Celcarb 150mg Injection can cause drowsiness, blurred vision, and dizziness. Driving is discouraged if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, Celcarb 150mg Injection requires careful administration and may necessitate dosage modification. Patients with severely compromised kidney function should avoid this injection. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Celcarb 150mg Injection in patients with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, though further information is limited. Physician consultation is advised.
What if you forget to take Celcarb 150mg Injection :
Omit a Celcarb 150mg Injection? Seek medical advice immediately.
Facts to Know About Celcarb 150mg Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-based Anticancer Agents |
3,018 People bought this recently